Companies: | 51,220 |
Products and Services: | 2,874 |
Articles and publications: | 31,100 (+5) |
Tenders & Vacancies: | 17 |
It is important for Pharmaceutical and health companies Preformulation Drug Compound Stability Solubility to have the required scientific knowledge before entering into the field of GLP Toxicology Formulation Development. The proper formulation techniques will help ensure that your compounds are safe enough to take into the body and to reach the intended end product.
Toxicity Testing - The toxicology of a compound or drug can be determined by examining the effects of that compound on various organ systems in the human body. This analysis is known as toxicity testing. Any pharmaceutical company will do it, but pharmaceutical companies are in the business of providing drugs and compounds to people to be used to treat illnesses, not as an instant fix to an ailment.
Often, the dosages required to take such compounds orally can be fatal. Proper human testing must be performed to ascertain the effects of the drug or compound before it reaches the consumer. The dosage must be large enough for the compound to cause no side effects, but not so large that it would be toxic to the consumer or any animal or human.
There are many dosage levels. Some are toxic, while others are not. Doses that cause no side effects may be mildly toxic to humans or even less toxic to animals. An animal may die if that compound was used on a human with an overdose, or possibly even a severe overdose in a person who does not suffer from normal toxicity levels.
Toxicity testing is an important step in GLP Toxicology Formulation Development. A medical-sized dose of a compound is known as a microdose. The dosage can be from just a little bit of a compound to a full blown overdose of a compound.
Not all dosage levels are dangerous. The toxicity level of a compound or drug is a general figure that helps define how much a human or animal can safely take.
Dose affects many parts of the body. A human cannot safely take a compound that has been set at such a low dosage level that it would be ineffectual. For example, the human body cannot tolerate doses of a drug that are deadly to an animal. Humans need doses that are not lethal in order to function.
The human metabolism may well be in a state where the compound is not properly absorbed, the metabolism is not up-regulated to take in the compound, or the receptor sites on the cell membrane are not healthy enough to receive the compound. When these factors come into play, the compound will be ineffective.
In order to determine how effective a particular drug or compound is toxicity testing needs to be performed on a variety of dosage levels of a compound or drug. This testing is performed to determine how a drug or compound will affect the human or animal and not just how it will affect the receptors on the cell membrane. It is important that you understand why before you even begin designing a GLP Toxicology Formulation Development process.
A medical perspective on toxicity testing is to determine how a compound or drug will affect the human or animal. On a regulatory perspective, the toxicology of a compound or drug determines how safe it is for human or animal consumption. The purpose of toxicity testing is to determine how safe the compound or drug is for human consumption. Toxicity testing may include toxicity studies, systemic toxicity studies, chronic toxicity studies, and even plant toxicity studies.
The studies in toxicology are generally qualitative, meaning that they study the chemical and it's effect in isolation and not as a whole. Toxicity studies are known as quantitative because they analyze the toxicity of a compound or drug as a whole by taking into consideration several variables of exposure such as dose, duration of exposure, route of exposure, and age of the subject.
Toxicity testing is done for safety for humans, animals, and plants that are being consumed in the clinical practice of toxicology. This is the toxicity of a compound or drug when it is used for human consumption.